Dr. Robert Fekete, MD

Dr. Fekete practices at Westchester Medical Center in Valhalla, New York, part of Westchester Medical Center Health Network.

Dr. Fekete's NPI, 1437318573, was assigned on June 4, 2008. Dr. Fekete graduated from New York University Grossman School of Medicine in 2005. Dr. Fekete holds New York license 248606.

Dr. Fekete's primary practice is Westchester Medical Center, at 100 Woods Rd, Valhalla, NY 10595 in Westchester County. The practice phone is (914) 493-7000.

Dr. Fekete's primary practice is Westchester Medical Center in Valhalla, New York, part of Westchester Medical Center Health Network. Dr. Fekete is also affiliated with Burke Rehabilitation Hospital. The medical group on file is Westchester Medical Center Advanced Physician Services. Dmand AI also links Dr. Fekete to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fekete practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Fekete's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Fekete's licenses on file in 2 states: New York and Texas.

CMS data shows 8,615 Medicare services from Dr. Fekete across 6 procedure codes in 2024, for 307 Medicare patients. Medicare paid $97,998 for them.

CMS counts 307 Medicare patients who saw Dr. Fekete in 2024. The largest group is 75 to 84, with 124 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 30% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fekete's median patient age at 68, with 50% women.

In 2024, Dr. Fekete wrote 2,628 Medicare Part D claims for 333 patients. 75% of them were for generic drugs. CMS names the drug for 2,421 of them, across 51 drugs with 11 or more claims each, at $2,024,780 in total drug cost. In 2023, CMS named 2,745 claims across 53 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Fekete for performance year 2024, reported as part of a group. Dr. Fekete accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fekete as offering telehealth.

Dmand AI links 33 papers to Dr. Fekete, published from 2011 to 2025. 2014 was the busiest year, with 3. The most frequent topics are Parkinson Disease, Essential Tremor and Hand Joints. Dr. Fekete has published most often in Case Rep Neurol. Dr. Fekete's most frequent co-authors are Joseph Jankovic, MD, Hasit Mehta, MD and Michelle Molina, MD.

Dmand AI links Dr. Fekete to 3 clinical trials. Conditions studied include Delusions, dopamine beta hydroxylase deficiency and Huntington Disease. Open Payments lists research payments to Dr. Fekete that name 1 trial.

CMS Open Payments shows 1,846 general payments to Dr. Fekete from 39 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 63% of the total. Neurocrine BioSciences, Inc. paid the most, $374,398. It also lists 2 research payments totaling $15,000 in 2019, naming 1 clinical trial.

Dr. Fekete graduated from New York University Grossman School of Medicine in 2005.